Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation

被引：56

作者：

Couriel, DR ^{[1
]}

Hicks, K ^{[1
]}

Giralt, S ^{[1
]}

Champlin, RE ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Div Med, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA

来源：

CURRENT OPINION IN ONCOLOGY | 2000年 / 12卷 / 06期

关键词：

D O I：

10.1097/00001622-200011000-00011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Tumor necrosis factor (TNF)-alpha is a central cytotoxic and proinflammatory cytokine, Research on the benefits of TNF-alpha inhibition as a form of therapy has focused almost exclusively on autoimmune, inflammatory disorders. InflixiMAB, a chimeric antibody to human TNF-alpha, was recently approved for the management of Crohn disease and rheumatoid arthritis. The potential applications of inflixiMAB in the management of cancer are just beginning to be explored. This article reviews the biology, mechanism of action, pharmacology, and toxicity of inflixiMAB. Existing clinical experience and inflixiMAB's potential role as an immunosuppressant and antitumor agent in the management of cancer are also discussed. Curr Opin Oncol 2000, 12:582-587 (C) 2000 Lippincott Williams & Wilkins, Inc.

引用

页码：582 / 587

页数：6

共 50 条

[21] Tumor necrosis factor-alpha and tumor necrosis factor beta polymorphisms and risk of breast cancer: Review
Aznag, Fatima Zahra
El Kadmiri, Nadia
Izaabel, El Hassan
GENE REPORTS, 2018, 12 : 317 - 323
[22] Chronic inhibition of tumor necrosis factor-alpha with infliximab improves myocardial deformation in parallel with aortic elasticity in rheumatoid arthritis
Ay, Birgul
Vural, Mustafa Gokhan
Ertem, Ahmet Goktug
Cagirci, Goksel
Akdemir, Ramazan
Efe, Tolga Han
Keskin, Goksal
Yeter, Ekrem
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2015, 43 (02): : 138 - 148
[23] Autoimmune Pitfalls of Anti-Tumor Necrosis Factor-Alpha Therapy
Roginic, Sinisa
Jelic, Alan
Stipic-Markovic, Asja
Marinko, Artukovic
Artukovic, Irena N.
Dusanka, Martinovic K.
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (02): : 117 - 119
[24] Alopecia secondary to Anti-Tumor Necrosis Factor-Alpha therapy
Prata Ribeiro, Lara Beatriz
Estrada, Bruna Duque
Pineiro Maceira, Juan Manuel
Goncalves Rego, Juliana Carlos
Bastos, Paula Raso
Sodre, Celso Tavares
ANAIS BRASILEIROS DE DERMATOLOGIA, 2015, 90 (02) : 232 - 235
[25] Nano anti-tumor necrosis factor-alpha based potentiometric sensor for tumor necrosis factor-alpha detection
Say, Ridan
Ozkutuk, Ebru Birlik
Unluer, Ozlem Bicen
Ugurag, Deniz
Ersoz, Arzu
SENSORS AND ACTUATORS B-CHEMICAL, 2015, 209 : 864 - 869
[26] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
Feldmann, M
Elliott, MJ
Woody, JN
Maini, RN
ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
[27] Aural cholesteatoma: Role of tumor necrosis factor-alpha in bone destruction
Sastry, KVSSR
Sharma, SC
Mann, SBS
Ganguly, NK
Panda, NK
AMERICAN JOURNAL OF OTOLOGY, 1999, 20 (02): : 158 - 161
[28] Role of tumor necrosis factor-alpha in the pathophysiology of idiopathic intracranial hypertension
Fahmy, Ebtesam Mohamed
Rashed, Laila Ahmed
Mostafa, Riham Hamdy
Ismail, Rania Shehata
ACTA NEUROLOGICA SCANDINAVICA, 2021, 144 (05): : 509 - 516
[29] TUMOR NECROSIS FACTOR-ALPHA (CACHECTIN) BIOLOGICAL PROPERTIES AND ROLE IN PHYSIOPATHOLOGY
BLAY, JY
CHOUAIB, S
PRESSE MEDICALE, 1989, 18 (19): : 975 - 979
[30] Role of tumor necrosis factor-alpha in regulating fibrotic lung repair
Dubaybo, BA
RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1998, 101 (01) : 69 - 83

← 1 2 3 4 5 →